Prokineticin Ligands and Receptors Are Expressed in the Human Fetal Ovary and Regulate Germ Cell Expression ofCOX2 | Zendy

Sharon L. Eddie | Zendy; Andrew J. Childs | Zendy; Hazel L. Kinnell | Zendy; Pamela Brown | Zendy; Henry N. Jabbour | Zendy; Richard A. Anderson | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Prokineticin Ligands and Receptors Are Expressed in the Human Fetal Ovary and Regulate Germ Cell Expression ofCOX2

Author(s) -

Sharon L. Eddie,

Andrew J. Childs,

Hazel L. Kinnell,

Pamela Brown,

Henry N. Jabbour,

Richard A. Anderson

Publication year - 2015

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2015-2330

Subject(s) - biology , ovary , medicine , endocrinology , germ cell , receptor , granulosa cell , folliculogenesis , fetus , microbiology and biotechnology , embryogenesis , embryo , pregnancy , genetics , gene

Fetal ovarian development and primordial follicle formation underpin future female fertility. Prokineticin (PROK) ligands regulate cell survival, proliferation, and angiogenesis in adult reproductive tissues including the ovary. However, their expression and function during fetal ovarian development remains unclear.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research